Starting in 2024, China has implemented a new tax policy that subjects medical aesthetic services to value-added tax (VAT), ending their previous exemption under certain healthcare provisions. This change has raised public concern: will cosmetic procedures become more expensive?According to guidelines from the State Taxation Administration, medical treatments for illnesses remain VAT-exempt, but non-therapeutic aesthetic procedures—such as rhinoplasty, liposuction, and hyaluronic acid injections—are now classified as ‘lifestyle services’ and subject to VAT at a standard rate of 6% or higher. This increases operating costs for clinics.However, whether prices will actually rise depends on multiple factors, including market competition, business strategies, and consumer tolerance. Large, established chains may absorb the additional tax burden through operational efficiencies or supply chain optimization, avoiding immediate price hikes. In contrast, smaller clinics with tighter margins might pass the cost onto customers.Overall, the policy aims to standardize taxation in the booming medical aesthetics industry and promote its healthy development. Consumers should prioritize clinic credentials and procedure safety over price alone. In the long run, this regulatory shift could accelerate industry consolidation, giving compliant, high-quality providers a competitive edge.
自2024年起，中国对医疗美容服务实施新的税收政策，明确将医美项目纳入增值税征税范围，不再享受此前部分医疗服务的免税待遇。这一政策调整引发公众关注：整容价格会不会因此上涨？根据国家税务总局的相关规定，原本用于疾病治疗的医疗行为可免征增值税，但以美容为目的的非治疗性医美项目（如隆鼻、抽脂、注射玻尿酸等）被认定为“生活性服务”，需按6%或更高税率缴纳增值税。这意味着医美机构的成本将有所上升。不过，是否涨价还需综合考虑市场竞争、机构运营策略及消费者接受度等因素。部分大型连锁医美机构可能通过优化供应链、提升效率来消化新增税负，短期内未必直接转嫁给消费者；而中小型机构若利润空间有限，则更可能上调服务价格。总体来看，新政旨在规范医美行业税收秩序，推动其健康发展。消费者在选择服务时，应更加关注机构资质与项目安全性，而非仅看价格变动。长远而言，行业洗牌或加速，优质合规机构将更具竞争力。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/10102.html